Filtered By:
Drug: Estradiol
Management: Insurance
This page shows you your search results in order of date.
Order by Relevance | Date
Total 2 results found since Jan 2013.
Hormone exposure and venous thromboembolism in commercially insured women aged 50 to 64 years
CONCLUSION: The risk of VTE is much lower with MHT than combined hormone contraceptives and varies by hormone formulation and route of exposure. Transdermal MHT did not elevate risk. Oral MHT combinations with estradiol were lower risk than other forms of estrogen. Oral combined hormone contraceptives had much higher risk than oral combined hormonal MHT.PMID:37193125 | PMC:PMC10182313 | DOI:10.1016/j.rpth.2023.100135
Source: Thrombosis and Haemostasis - May 16, 2023 Category: Hematology Authors: Susan C Weller John W Davis Laura Porterfield Lu Chen Gregg Wilkinson Source Type: research
